- Home
- MIST vs CODA Comparison
MIST vs CODA Comparison
Compare MIST & CODA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIST
- CODA
- Stock Information
- Founded
- MIST 2003
- CODA 1994
- Country
- MIST Canada
- CODA United States
- Employees
- MIST N/A
- CODA N/A
- Industry
- MIST Biotechnology: Pharmaceutical Preparations
- CODA Industrial Machinery/Components
- Sector
- MIST Health Care
- CODA Industrials
- Exchange
- MIST Nasdaq
- CODA Nasdaq
- Market Cap
- MIST 100.3M
- CODA 99.0M
- IPO Year
- MIST N/A
- CODA N/A
- Fundamental
- Price
- MIST $1.81
- CODA $8.38
- Analyst Decision
- MIST Strong Buy
- CODA Strong Buy
- Analyst Count
- MIST 3
- CODA 1
- Target Price
- MIST $13.00
- CODA $11.00
- AVG Volume (30 Days)
- MIST 372.6K
- CODA 57.8K
- Earning Date
- MIST 11-12-2024
- CODA 01-27-2025
- Dividend Yield
- MIST N/A
- CODA N/A
- EPS Growth
- MIST N/A
- CODA N/A
- EPS
- MIST N/A
- CODA 0.26
- Revenue
- MIST N/A
- CODA $18,824,676.00
- Revenue This Year
- MIST N/A
- CODA $8.20
- Revenue Next Year
- MIST N/A
- CODA $18.67
- P/E Ratio
- MIST N/A
- CODA $31.58
- Revenue Growth
- MIST N/A
- CODA N/A
- 52 Week Low
- MIST $1.12
- CODA $5.21
- 52 Week High
- MIST $2.93
- CODA $9.89
- Technical
- Relative Strength Index (RSI)
- MIST 49.60
- CODA 39.89
- Support Level
- MIST $1.76
- CODA $8.14
- Resistance Level
- MIST $1.86
- CODA $9.06
- Average True Range (ATR)
- MIST 0.10
- CODA 0.34
- MACD
- MIST -0.02
- CODA -0.13
- Stochastic Oscillator
- MIST 18.93
- CODA 12.41
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About CODA Coda Octopus Group Inc. Common stock
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. It operates in two segments: Marine Technology Business and Marine Engineering Business. The Technology Business develops proprietary solutions for both the commercial and defense subsea market. Its solutions include hardware and software for Geophysical Systems, Motion & Positioning Systems, and Real-Time Volumetric Imaging Sonar. The Engineering Business segment provides engineering services to a range of clients in the defense markets. Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Marine Technology Business segment.